Your browser doesn't support javascript.
loading
Infections in patients with rheumatoid arthritis receiving tofacitinib versus tumour necrosis factor inhibitors: results from the open-label, randomised controlled ORAL Surveillance trial.
Balanescu, Andra-Rodica; Citera, Gustavo; Pascual-Ramos, Virginia; Bhatt, Deepak L; Connell, Carol A; Gold, David; Chen, All-Shine; Sawyerr, Gosford; Shapiro, Andrea B; Pope, Janet E; Schulze-Koops, Hendrik.
Afiliação
  • Balanescu AR; Department of Internal Medicine and Rheumatology, Carol Davila University of Medicine and Pharmacy, Sf Maria Hospital, Bucharest, Romania.
  • Citera G; Department of Rheumatology, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina.
  • Pascual-Ramos V; Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Bhatt DL; Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Connell CA; Pfizer Inc, Groton, Connecticut, USA.
  • Gold D; Pfizer Canada ULC, Kirkland, Montreal, Canada David.Gold@pfizer.com.
  • Chen AS; Pfizer Inc, Groton, Connecticut, USA.
  • Sawyerr G; Pfizer Inc, New York, New York, USA.
  • Shapiro AB; Pfizer Inc, Peapack, New Jersey, USA.
  • Pope JE; Division of Rheumatology, Western University, London, Ontario, Canada.
  • Schulze-Koops H; Division of Rheumatology and Clinical Immunology, Department of Internal Medicine IV, Ludwig Maximilians University Munich, Munich, Germany.
Ann Rheum Dis ; 81(11): 1491-1503, 2022 11.
Article em En | MEDLINE | ID: mdl-35922124

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Antirreumáticos / Pneumopatias Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Female / Humans Idioma: En Revista: Ann Rheum Dis Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Romênia

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Antirreumáticos / Pneumopatias Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Female / Humans Idioma: En Revista: Ann Rheum Dis Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Romênia